FROOME CLOSE
Medical Technologies
Drug Calculator
Health Economics
Drug AE
Drug Label
Drug Sync
← Main site
Health Economics — Froome Close
← Health Economics
Myelodysplastic syndrome
Select a treatment setting
First-line/Induction
First-line therapy
Regimens
14
With dosing
13
›
Consolidation
Consolidation after first-line therapy
Regimens
2
With dosing
2
›
Relapsed/Refractory/Later-line
IDH1 relapsed or refractory
1 biomarker
Regimens
1
With dosing
1
›
Relapsed or refractory
Regimens
3
With dosing
2
›
Other
Lower-risk MDS all lines of therapy
Regimens
8
With dosing
7
›
Lower-risk MDS, all lines of therapy
Regimens
1
With dosing
0
›